tiprankstipranks
Trending News
More News >
Innate Pharma SA Sponsored ADR (IPHA)
:IPHA
US Market
Advertisement

Innate Pharma (IPHA) Financial Statements

Compare
118 Followers

Innate Pharma Financial Overview

Innate Pharma's market cap is currently $157.77M. The company's EPS TTM is $-0.346; its P/E ratio is ―; Innate Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 12.62M€ 51.90M€ 57.67M€ 12.11M€ 69.77M
Gross Profit€ 12.62M€ -4.12M€ -2.02M€ -34.89M€ 20.07M
Operating Income€ -51.58M€ -12.67M€ -57.42M€ -47.83M€ 1.08M
EBITDA€ -46.91M€ -1.84M€ -12.28M€ -43.23M€ 13.30M
Net Income€ -49.47M€ -7.57M€ -58.10M€ -59.14M€ -63.98M
Balance Sheet
Cash & Short-Term Investments€ 80.77M€ 92.46M€ 101.48M€ 119.84M€ 151.64M
Total Assets€ 111.06M€ 184.19M€ 207.86M€ 267.50M€ 307.42M
Total Debt€ 31.00M€ 39.89M€ 42.25M€ 44.25M€ 19.09M
Net Debt€ -35.40M€ -30.71M€ -41.97M€ -59.51M€ -117.70M
Total Liabilities€ 102.22M€ 132.29M€ 153.71M€ 160.06M€ 151.45M
Stockholders' Equity€ 8.83M€ 51.90M€ 54.15M€ 107.44M€ 155.97M
Cash Flow
Free Cash Flow€ -7.29M€ -34.91M€ -20.28M€ -59.79M€ -63.09M
Operating Cash Flow€ -6.90M€ -32.56M€ -19.15M€ -58.46M€ -51.81M
Investing Cash Flow€ 9.20M€ 20.63M€ 1.88M€ -917.00K€ -13.37M
Financing Cash Flow€ -6.01M€ -1.97M€ -1.83M€ 26.82M€ -1.14M
Currency in EUR

Innate Pharma Earnings and Revenue History

Innate Pharma Debt to Assets

Innate Pharma Cash Flow

Innate Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis